Blood Glucose Fluctuations in Type 2 Diabetes Patients Treated with Multiple Daily Injections

Table 4

Blood glucose fluctuations of long-standing T2DM patients.

	CSII N Group	MDI3 N Group	MDI4 N Group
24 h MBG (mmol/L)
Before therapy	10.80 ± 2.82	10.00 ± 2.60	11.43 ± 3.19
After therapy	7.69 ± 2.24	7.65 ± 1.15	8.07 ± 1.40
MAGE
Before therapy	6.56 ± 2.77	6.95 ± 2.74	6.48 ± 3.15
After therapy	4.62 ± 2.97	6.27 ± 1.83	5.16 ± 1.98
The time spent (>10 mmol/L) (%)
Before therapy	60 ± 32	65 ± 27	62 ± 36
After therapy	16 ± 17	19 ± 10	18 ± 15
The time spent in <3.9 mmol/L (%)
Before therapy	3 ± 9	4 ± 5	1 ± 2
After therapy	0.2 ± 0.2	0.4 ± 0.1	0.2 ± 0.3
The time spent in normal glycaemia (%)
Before therapy	39 ± 31	33 ± 29	38 ± 36
After therapy	83 ± 17	73 ± 10	79 ± 11
The AUC (>10 mmol/L) (mmol/L per day)
Before therapy	2.34 ± 2.12	2.77 ± 1.73	2.93 ± 2.50
After therapy	0.25 ± 0.60	0.37 ± 0.27	0.28 ± 0.09
The AUC for <3.9 mmol/L (mmol/L per day)
Before therapy	0.02 ± 0.08	0.02 ± 0.04	0.06 ± 0.02
After therapy	0.00 ± 0.00	0.00 ± 0.00	0.00 ± 0.00

Data are mean ± (SD). , versus the same item before therapy; versus MDI3 N group after therapy.